Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. (Q45870090)
Jump to navigation
Jump to search
scientific article published on 8 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. |
scientific article published on 8 August 2007 |
Statements
1 reference
Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. (English)
1 reference
L X Chen
1 reference
L Lin
1 reference
H J Wang
1 reference
X L Wei
1 reference
X Fu
1 reference
J Y Zhang
1 reference
C L Yu
1 reference
8 August 2007
1 reference
1 reference
16
1 reference
174-184
1 reference
2
1 reference
1 reference
Identifiers
1 reference
1 reference